Quantcast

Latest Chronic lower respiratory diseases Stories

2014-09-11 04:21:18

OXFORD, England, September 11, 2014 /PRNewswire/ -- Successful Completion of Biomedical Catalyst Programme Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that it has confirmed the potential of its Multi-component Particle(TM) (MCP(TM)) Technology for creating novel inhaled, dual and triple fixed dose combination (FDC) therapies for respiratory diseases. The Company...

2014-09-09 12:28:55

Breathe NIOV System Also Wins European Respiratory Society POINT Award IRVINE, Calif., Sept. 9, 2014 /PRNewswire/ -- Breathe Technologies, a developer and manufacturer of innovative medical technologies for patients with respiratory insufficiency diseases and neuromuscular diseases, announced today that it received CE Certification for its Non-Invasive Open Ventilation (NIOV) System, enabling the company to market and sell the device in the European Union. In addition, the NIOV...

2014-09-09 08:31:47

LONDON, ON, Sept. 9, 2014 /PRNewswire/ - New study results presented today at the European Respiratory Society (ERS) Conference in Munich Germany provide further evidence that the Aerobika* OPEP device developed by Trudell Medical International (TMI) provides an important treatment for the 250 million patients suffering from COPD globally. Many of these patients suffer from excessive mucus resulting in breathlessness, the inability to do everyday activities, and decreased quality of...

2014-09-08 16:24:59

WWII Veteran Bob Scott to Tour Washington, D.C. Memorials Using the Breathe NIOV System IRVINE, Calif., Sept. 8, 2014 /PRNewswire/ -- Breathe Technologies, a developer and manufacturer of innovative medical technologies for patients with respiratory insufficiency diseases and neuromuscular diseases, will sponsor World War II Veteran and Colton, Calif. resident Bob Scott on a September trip to Washington, D.C., as part of the Honor Flight Network. The Breathe Non-Invasive Open...

2014-09-08 12:29:32

For U.S. Media Only RIDGEFIELD, Conn., Sept. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented new data from the company's Phase III trial program (UniTinA-asthma(®)) evaluating tiotropium in asthma, including the first study assessing the efficacy and safety of tiotropium in adolescent patients with symptomatic asthma. These data were unveiled during an oral session at the European Respiratory Society (ERS) International Congress 2014 in Munich, Germany. Tiotropium is...

2014-09-08 08:29:55

-- LANTERN study met primary endpoint demonstrating non-inferiority of Ultibro® Breezhaler® 110/50 mcg vs Advair* Diskus* (SFC) 50/500 mcg followed by statistically significant superiority in post dose trough FEV1 after 26 weeks of treatment in patients with moderate-to-severe COPD1 -- In addition, LANTERN study met an endpoint demonstrating that Ultibro®Breezhaler ® reduced...

2014-09-04 23:03:46

MedicationDiscountCard.com offers Veramyst discount cards, along with discount cards for other similar medications. These discount cards can save patients 10-75% on prescription drugs that treat or help manage COPD. Margate City, NJ (PRWEB) September 04, 2014 Recent reports from the Centers for Disease Control indicate that nearly 7% of the US population is currently dealing with chronic obstructive pulmonary disease, or COPD (cdc.gov/Features/copdadults/). It may also be called COLD...

2014-08-19 12:28:32

For U.S. Media Only RIDGEFIELD, Conn., Aug. 19, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for the fixed-dose combination (FDC) of tiotropium and olodaterol delivered via the Respimat(®) inhaler for the proposed indication of long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including...

2014-08-01 08:26:18

For U.S. Media Only RIDGEFIELD, Conn., Aug. 1, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved Striverdi(®) Respimat(®) (olodaterol) Inhalation Spray 5 mcg as a long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. STRIVERDI RESPIMAT is not indicated to treat acute...

COPD Costs
2014-07-30 05:03:01

Rayshell Clapper for redOrbit.com - Your Universe Online Smoking cigarettes is bad on all levels. It can bring on heart disease (the number one killer of men and women in America), aggravate pre-existing conditions such as diabetes, and lead to lung diseases such as cancer or Chronic Obstructive Pulmonary Disease (COPD), just to name a few. Smoking has its dirty fingers in many of the mental and physical health conditions that ail Americans. COPD is one of the many chronic lower...


Latest Chronic lower respiratory diseases Reference Libraries

Lung
2013-01-01 15:53:59

The lung is a vital organ that is a part of the respiratory system. Generally a person has two lungs; however, the body can function with only one. The lung’s main function is to move oxygen and carbon dioxide into and out of the bloodstream through gas exchange. The lungs are located lateral to the heart in the thoracic cavity. Each lung has a tip called the apex, which is superior in the body. The bases of the lungs rest on the diaphragm. They appear to be spongy due to their bundles of...

More Articles (1 articles) »
Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related